Assessment of the consistency and robustness of results from a multicenter trial of remission maintenance therapy for acute myeloid leukemia

BACKGROUND: Data from a randomized multinational phase 3 trial of 320 adults with acute myeloid leukemia (AML) demonstrated that maintenance therapy with 3-week cycles of histamine dihydrochloride plus low-dose interleukin-2 (HDC/IL-2) for up to 18 months significantly improved leukemia-free surviva...

詳細記述

保存先:
書誌詳細
主要な著者: Buyse, Marc, Squifflet, Pierre, Lucchesi, Kathryn J, Brune, Mats L, Castaigne, Sylvie, Rowe, Jacob M
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2011
主題:
Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3077323/
https://ncbi.nlm.nih.gov/pubmed/21429214
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1745-6215-12-86
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料